Towards a fully humanized iPSC-derived neural network for translatable cognitive drug screening
With the prospect of better translation compared to mouse systems, human IPSC-derived neuronal networks are a promising model system to overcome the valley of death in cognitive drug discovery for neurodegenerative disease. Synapse strengthening may prevent or reverse neurodegeneration. However, screening for compounds that achieve this requires a network capable of synapse strengthening and weakening that is supported by human astrocytes and microglia, i.e. a fully human model system of a minimal brain circuit.So far, convincing post-synaptic immunostains of hIPSC-derived neurons are rare, as